Indian Pharmas Seeking Foreign Acquisitions Find Selectivity Need
This article was originally published in PharmAsia News
Executive Summary
Indian drug makers are finding large foreign acquisitions harder to find, leading some firms to be more sophisticated in their selection process. One consultant said Indian companies have specific objectives about the part of the market in which they wish to acquire players. That selectivity could include acquisitions of patents, a brand or its distribution as well as a sub-segment of the market. Although large acquisitions are expected to continue, companies seeking to acquire others will have to look beyond conventional considerations in making the decision, the consultant says. (Click here for more